Providence Health & Services
Clinical trials sponsored by Providence Health & Services, explained in plain language.
-
Could a Sugar-Blocking pill boost immunotherapy for tough cancers?
Disease control Recruiting nowThis phase 2 trial tests whether adding an experimental pill (GB1211) to the immunotherapy drug pembrolizumab (Keytruda) works better than Keytruda alone for people with advanced melanoma or head and neck cancer. The study will enroll 92 participants and measure how many patients…
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New vaccine combo aims to control advanced head and neck cancer
Disease control Recruiting nowThis early-phase study tests a new cancer vaccine (DPV-001) combined with two immunotherapy drugs in people with head and neck cancer that has returned or spread. The goal is to see if the combination is safe and can help control the cancer. About 56 adults with recurrent or meta…
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental drug combo aims to shrink aggressive breast tumors before surgery
Disease control Recruiting nowThis phase II trial tests whether adding an experimental drug called INBRX-106 to the immunotherapy pembrolizumab (Keytruda) can shrink tumors in people with stage II or III triple-negative breast cancer before they receive standard chemotherapy. The study will enroll 12 adults w…
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC